Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.08.16.504129

Large-scale network metrics improve the classification performance of rapid-eye-movement sleep behavior disorder patients

Abstract

Clinical decision support systems based on machine-learning algorithms are largely applied in the context of the diagnosis of neurodegenerative diseases (NDDs). While recent models yield robust classifications in supervised two classes-problems accurately separating Parkinsons disease (PD) from healthy control (HC) subjects, few works looked at prodromal stages of NDDs. Idiopathic Rapid-eye Movement (REM) sleep behavior disorder (iRBD) is considered a prodromal stage of PD with a high chance of phenoconversion but with heterogeneous symptoms that hinder accurate disease prediction. Machine learning (ML) based methods can be used to develop personalized trajectory models, but these require large amounts of observational points with homogenous features significantly reducing the possible imaging modalities to non-invasive and cost-effective techniques such as high-density electrophysiology (hdEEG). In this work, we aimed at quantifying the increase in accuracy and robustness of the classification model with the inclusion of network-based metrics compared to the classical Fourier-based power spectral density (PSD). We performed a series of analyses to quantify significance in cohort-wise metrics, the performance of classification tasks, and the effect of feature selection on model accuracy. We report that amplitude correlation spectral profiles show the largest difference between iRBD and HC subjects mainly in delta and theta bands. Moreover, the inclusion of amplitude correlation and phase synchronization improves the classification performance by up to 11% compared to using PSD alone. Our results show that hdEEG features alone can be used as potential biomarkers in classification problems using iRBD data and that large-scale network metrics improve the performance of the model. This evidence suggests that large-scale brain network metrics should be considered important tools for investigating prodromal stages of NDD as they yield more information without harming the patient, allowing for constant and frequent longitudinal evaluation of patients at high risk of phenoconversion. HighlightsO_LINetwork-based features are important tools to investigate prodromal stages of PD C_LIO_LIAmplitude correlation shows the largest difference between two groups in 9/30 bands C_LIO_LIAmplitude correlation improved up to 11% the performance compared to PSD alone C_LIO_LIClassification robustness increases when we use both network-based EEG features C_LIO_LIClassifier performance worsens when PSD is added to network-based EEG features C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Roascio, M., Turrisi, R., Arnaldi, D., Fama, F., Mattioli, P., Nobili, F. M., Barla, A., Arnulfo, G.. 2022-08-17. Large-scale network metrics improve the classification performance of rapid-eye-movement sleep behavior disorder patients. https://doi.org/10.1101/2022.08.16.504129

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Comparative study of chlorophyll measurement in Physcomitrium patens moss using a conventional microscope adapted for combined 2D+1D imaging and spectral analysis

Imaging spectroscopy often requires expensive and complex equipment. Here we show a simple procedure for attaching a standard miniature fiber spectrometer to a conventional microscope, allowing easy integration of 2D imaging with 1D high-resolution spectral measurements. This combination provides much of the benefit of a full imaging spectrometer without the large equipment investment, and we provide instructions for modifying microscopes to this setup and the present measurements of living cells that demonstrate their performance. Using this setup, we compare the quantitative measurement of chlorophyll concentration in Physcomitrium patens moss using color imaging and spectral sampling.

bioengineering↗

De novo designed single-domain antibodies protect against lethal cobra venom neurotoxicity in vivo

Generative protein design can now rapidly produce de novo binders with high affinity and functional activity against a wide range of targets, including lethal snake venom toxins. However, so far most reported successes rely on new-to-nature scaffolds with limited therapeutic precedent. Single-domain antibodies (VHHs) offer a clinically validated alternative scaffold that can bind and neutralize long-chain -neurotoxins, which are some of the most lethal components in snake venoms. Here we compare three recently established de novo design models with VHH-design capabilities (Germinal, RFantibody, and BoltzGen) for their ability to generate VHHs against the neurotoxin -cobratoxin from the monocled cobra (Naja kaouthia). Using standardized model inputs and evaluation criteria based on AlphaFold3 interface confidence (ipTM) and RMSD self-consistency, we find that Germinal was the only method to generate designs passing stringent in silico criteria for experimental testing. We therefore performed a larger Germinal design campaign employing three different VHH frameworks and experimentally validated 46 designs in vitro. Of these, 42 expressed as soluble proteins and we identified four binding hits derived from two of the three tested frameworks. Of the four binders, two lead candidates were further characterized and demonstrated high affinity (KDs of 4.1 nM and 10.8 nM), monomeric behavior and low polyreactivity, indicating favorable biophysical and developability properties, as well as functional toxin neutralization in vitro. To assess their therapeutic potential we investigated their ability to protect against -cobratoxin toxicity in vivo. Both candidates fully protected mice after -cobratoxin challenge, with 100% survival compared to a lethal control. One candidate also retained notable neutralization capacity against whole venom of Naja kaouthia with a survival of 56%, while the other protected 22% when tested in a rescue setting. Together, we demonstrate that de novo VHH design can generate high affinity single-domain antibodies with in vivo protection against lethal cobra venom neurotoxicity, and provide practical insights into method- and framework-dependent performance.

bioengineering↗

Simple Feedback for Complex Movement: Capturing Whole-Limb Reorganization during Single-IMU Gait Retraining

Clinical gait retraining typically relies on multi-sensor arrays and high-dimensional feedback displays, imposing setup and interpretation burdens that limit routine clinical deployment. We developed a single-IMU visual biofeedback system that delivers real-time feedback of Lower Limb Trajectory Error (LLTE), a composite kinematic error metric integrating knee position and shank angle across the stance phase. Twenty able-bodied adults walked on a treadmill under two visual biofeedback targets (flexed-knee, extended-knee) while receiving either corrected (n=10) or uncorrected (n=8) feedback, where the correction accounted for limb orientation at initial contact. LLTE and stance-phase knee kinematics adapted consistently under the flexed-knee target for both feedback groups, with feedback formulation moderating the temporal trajectory of change. Adaptation toward the extended-knee target was limited, likely because participants were already operating near terminal knee extension and because the scalar error metric provided limited directional information for correction. Ankle range of motion (ROM) changed significantly across the stance phase under both target conditions, while hip ROM did not. Multiscale multivariate sample entropy (MSMVSE) increased monotonically with time scale across all conditions, with no statistically distinguishable difference between corrected and uncorrected feedback. These results suggest that single-IMU LLTE biofeedback can modify gait mechanics and that adaptation was expressed across multiple lower-limb segments rather than through changes at a single joint.

bioengineering↗